The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Transcatheter Aortic Valve Replacement (TAVR)-Global Market Insights and Sales Trends 2025
Synopsis
Transcatheter Aortic Valve Replacement (TAVR), also referred as Transcatheter Aortic Valve Implantation (TAVI) is a minimally invasive surgical procedure repairs the valve without removing the old, damaged valve. Instead, it wedges a replacement valve into the aortic valve's place. Normally valve replacement method requires an open heart procedure with a sternotomy, in which the chest is surgically separated for the treatment. The TAVR procedures can be done through very small openings that leave all the chest bones in place.
The global Transcatheter Aortic Valve Replacement (TAVR) market size is expected to reach US$ 12060 million by 2029, growing at a CAGR of 16.8% from 2023 to 2029. The market is mainly driven by the significant applications of Transcatheter Aortic Valve Replacement (TAVR) in various end use industries. The expanding demands from the Aortic Stenosis, Aortic Regurgitation and Others,, are propelling Transcatheter Aortic Valve Replacement (TAVR) market. Transfemoral Approach, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Transapical Approach segment is estimated at % CAGR for the next seven-year period.
In China, Transcatheter Aortic Valve Replacement (TAVR) key players include Venus Medtech, Suzhou Jiecheng Medical Technology Co., Peijia Medical, etc.
East China is the largest consumer region of transcatheter aortic valve replacement in China, followed by North and South China.
In terms of product, Transfemoral Approach is the largest segment, with a share over 80%. And in terms of application, the largest application is Aortic Stenosis, followed by Aortic Regurgitation.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Transcatheter Aortic Valve Replacement (TAVR), with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Transcatheter Aortic Valve Replacement (TAVR) market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Transcatheter Aortic Valve Replacement (TAVR) market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Transcatheter Aortic Valve Replacement (TAVR) sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Transcatheter Aortic Valve Replacement (TAVR) covered in this report include Edwards Lifesciences, Medtronic, Abbott, Boston Scientific, Meril Life Sciences, Venus Medtech, Bracco (HLT), JenaValve Technology and Suzhou Jiecheng Medical Technology Co., etc.
The global Transcatheter Aortic Valve Replacement (TAVR) market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Edwards Lifesciences
Medtronic
Abbott
Boston Scientific
Meril Life Sciences
Venus Medtech
Bracco (HLT)
JenaValve Technology
Suzhou Jiecheng Medical Technology Co.
Peijia Medical
Global Transcatheter Aortic Valve Replacement (TAVR) market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Transcatheter Aortic Valve Replacement (TAVR) market, Segment by Type:
Transfemoral Approach
Transapical Approach
Others
Global Transcatheter Aortic Valve Replacement (TAVR) market, by Application
Aortic Stenosis
Aortic Regurgitation
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Transcatheter Aortic Valve Replacement (TAVR) companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Transcatheter Aortic Valve Replacement (TAVR), also referred as Transcatheter Aortic Valve Implantation (TAVI) is a minimally invasive surgical procedure repairs the valve without removing the old, damaged valve. Instead, it wedges a replacement valve into the aortic valve's place. Normally valve replacement method requires an open heart procedure with a sternotomy, in which the chest is surgically separated for the treatment. The TAVR procedures can be done through very small openings that leave all the chest bones in place.
The global Transcatheter Aortic Valve Replacement (TAVR) market size is expected to reach US$ 12060 million by 2029, growing at a CAGR of 16.8% from 2023 to 2029. The market is mainly driven by the significant applications of Transcatheter Aortic Valve Replacement (TAVR) in various end use industries. The expanding demands from the Aortic Stenosis, Aortic Regurgitation and Others,, are propelling Transcatheter Aortic Valve Replacement (TAVR) market. Transfemoral Approach, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Transapical Approach segment is estimated at % CAGR for the next seven-year period.
In China, Transcatheter Aortic Valve Replacement (TAVR) key players include Venus Medtech, Suzhou Jiecheng Medical Technology Co., Peijia Medical, etc.
East China is the largest consumer region of transcatheter aortic valve replacement in China, followed by North and South China.
In terms of product, Transfemoral Approach is the largest segment, with a share over 80%. And in terms of application, the largest application is Aortic Stenosis, followed by Aortic Regurgitation.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Transcatheter Aortic Valve Replacement (TAVR), with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Transcatheter Aortic Valve Replacement (TAVR) market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Transcatheter Aortic Valve Replacement (TAVR) market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Transcatheter Aortic Valve Replacement (TAVR) sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Transcatheter Aortic Valve Replacement (TAVR) covered in this report include Edwards Lifesciences, Medtronic, Abbott, Boston Scientific, Meril Life Sciences, Venus Medtech, Bracco (HLT), JenaValve Technology and Suzhou Jiecheng Medical Technology Co., etc.
The global Transcatheter Aortic Valve Replacement (TAVR) market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Edwards Lifesciences
Medtronic
Abbott
Boston Scientific
Meril Life Sciences
Venus Medtech
Bracco (HLT)
JenaValve Technology
Suzhou Jiecheng Medical Technology Co.
Peijia Medical
Global Transcatheter Aortic Valve Replacement (TAVR) market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Transcatheter Aortic Valve Replacement (TAVR) market, Segment by Type:
Transfemoral Approach
Transapical Approach
Others
Global Transcatheter Aortic Valve Replacement (TAVR) market, by Application
Aortic Stenosis
Aortic Regurgitation
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Transcatheter Aortic Valve Replacement (TAVR) companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Transcatheter Aortic Valve Replacement (TAVR)
1.1 Transcatheter Aortic Valve Replacement (TAVR) Market Overview
1.1.1 Transcatheter Aortic Valve Replacement (TAVR) Product Scope
1.1.2 Transcatheter Aortic Valve Replacement (TAVR) Market Status and Outlook
1.2 Global Transcatheter Aortic Valve Replacement (TAVR) Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Transcatheter Aortic Valve Replacement (TAVR) Market Size by Region (2018-2029)
1.4 Global Transcatheter Aortic Valve Replacement (TAVR) Historic Market Size by Region (2018-2023)
1.5 Global Transcatheter Aortic Valve Replacement (TAVR) Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Transcatheter Aortic Valve Replacement (TAVR) Market Size (2018-2029)
1.6.1 North America Transcatheter Aortic Valve Replacement (TAVR) Market Size (2018-2029)
1.6.2 Europe Transcatheter Aortic Valve Replacement (TAVR) Market Size (2018-2029)
1.6.3 Asia-Pacific Transcatheter Aortic Valve Replacement (TAVR) Market Size (2018-2029)
1.6.4 Latin America Transcatheter Aortic Valve Replacement (TAVR) Market Size (2018-2029)
1.6.5 Middle East & Africa Transcatheter Aortic Valve Replacement (TAVR) Market Size (2018-2029)
2 Transcatheter Aortic Valve Replacement (TAVR) Market by Type
2.1 Introduction
2.1.1 Transfemoral Approach
2.1.2 Transapical Approach
2.1.3 Others
2.2 Global Transcatheter Aortic Valve Replacement (TAVR) Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Transcatheter Aortic Valve Replacement (TAVR) Historic Market Size by Type (2018-2023)
2.2.2 Global Transcatheter Aortic Valve Replacement (TAVR) Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Transcatheter Aortic Valve Replacement (TAVR) Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Transcatheter Aortic Valve Replacement (TAVR) Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Transcatheter Aortic Valve Replacement (TAVR) Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Transcatheter Aortic Valve Replacement (TAVR) Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Transcatheter Aortic Valve Replacement (TAVR) Revenue Breakdown by Type (2018-2029)
3 Transcatheter Aortic Valve Replacement (TAVR) Market Overview by Application
3.1 Introduction
3.1.1 Aortic Stenosis
3.1.2 Aortic Regurgitation
3.1.3 Others
3.2 Global Transcatheter Aortic Valve Replacement (TAVR) Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Transcatheter Aortic Valve Replacement (TAVR) Historic Market Size by Application (2018-2023)
3.2.2 Global Transcatheter Aortic Valve Replacement (TAVR) Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Transcatheter Aortic Valve Replacement (TAVR) Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Transcatheter Aortic Valve Replacement (TAVR) Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Transcatheter Aortic Valve Replacement (TAVR) Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Transcatheter Aortic Valve Replacement (TAVR) Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Transcatheter Aortic Valve Replacement (TAVR) Revenue Breakdown by Application (2018-2029)
4 Transcatheter Aortic Valve Replacement (TAVR) Competition Analysis by Players
4.1 Global Transcatheter Aortic Valve Replacement (TAVR) Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Transcatheter Aortic Valve Replacement (TAVR) as of 2022)
4.3 Date of Key Players Enter into Transcatheter Aortic Valve Replacement (TAVR) Market
4.4 Global Top Players Transcatheter Aortic Valve Replacement (TAVR) Headquarters and Area Served
4.5 Key Players Transcatheter Aortic Valve Replacement (TAVR) Product Solution and Service
4.6 Competitive Status
4.6.1 Transcatheter Aortic Valve Replacement (TAVR) Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Edwards Lifesciences
5.1.1 Edwards Lifesciences Profile
5.1.2 Edwards Lifesciences Main Business
5.1.3 Edwards Lifesciences Transcatheter Aortic Valve Replacement (TAVR) Products, Services and Solutions
5.1.4 Edwards Lifesciences Transcatheter Aortic Valve Replacement (TAVR) Revenue (US$ Million) & (2018-2023)
5.1.5 Edwards Lifesciences Recent Developments
5.2 Medtronic
5.2.1 Medtronic Profile
5.2.2 Medtronic Main Business
5.2.3 Medtronic Transcatheter Aortic Valve Replacement (TAVR) Products, Services and Solutions
5.2.4 Medtronic Transcatheter Aortic Valve Replacement (TAVR) Revenue (US$ Million) & (2018-2023)
5.2.5 Medtronic Recent Developments
5.3 Abbott
5.3.1 Abbott Profile
5.3.2 Abbott Main Business
5.3.3 Abbott Transcatheter Aortic Valve Replacement (TAVR) Products, Services and Solutions
5.3.4 Abbott Transcatheter Aortic Valve Replacement (TAVR) Revenue (US$ Million) & (2018-2023)
5.3.5 Boston Scientific Recent Developments
5.4 Boston Scientific
5.4.1 Boston Scientific Profile
5.4.2 Boston Scientific Main Business
5.4.3 Boston Scientific Transcatheter Aortic Valve Replacement (TAVR) Products, Services and Solutions
5.4.4 Boston Scientific Transcatheter Aortic Valve Replacement (TAVR) Revenue (US$ Million) & (2018-2023)
5.4.5 Boston Scientific Recent Developments
5.5 Meril Life Sciences
5.5.1 Meril Life Sciences Profile
5.5.2 Meril Life Sciences Main Business
5.5.3 Meril Life Sciences Transcatheter Aortic Valve Replacement (TAVR) Products, Services and Solutions
5.5.4 Meril Life Sciences Transcatheter Aortic Valve Replacement (TAVR) Revenue (US$ Million) & (2018-2023)
5.5.5 Meril Life Sciences Recent Developments
5.6 Venus Medtech
5.6.1 Venus Medtech Profile
5.6.2 Venus Medtech Main Business
5.6.3 Venus Medtech Transcatheter Aortic Valve Replacement (TAVR) Products, Services and Solutions
5.6.4 Venus Medtech Transcatheter Aortic Valve Replacement (TAVR) Revenue (US$ Million) & (2018-2023)
5.6.5 Venus Medtech Recent Developments
5.7 Bracco (HLT)
5.7.1 Bracco (HLT) Profile
5.7.2 Bracco (HLT) Main Business
5.7.3 Bracco (HLT) Transcatheter Aortic Valve Replacement (TAVR) Products, Services and Solutions
5.7.4 Bracco (HLT) Transcatheter Aortic Valve Replacement (TAVR) Revenue (US$ Million) & (2018-2023)
5.7.5 Bracco (HLT) Recent Developments
5.8 JenaValve Technology
5.8.1 JenaValve Technology Profile
5.8.2 JenaValve Technology Main Business
5.8.3 JenaValve Technology Transcatheter Aortic Valve Replacement (TAVR) Products, Services and Solutions
5.8.4 JenaValve Technology Transcatheter Aortic Valve Replacement (TAVR) Revenue (US$ Million) & (2018-2023)
5.8.5 JenaValve Technology Recent Developments
5.9 Suzhou Jiecheng Medical Technology Co.
5.9.1 Suzhou Jiecheng Medical Technology Co. Profile
5.9.2 Suzhou Jiecheng Medical Technology Co. Main Business
5.9.3 Suzhou Jiecheng Medical Technology Co. Transcatheter Aortic Valve Replacement (TAVR) Products, Services and Solutions
5.9.4 Suzhou Jiecheng Medical Technology Co. Transcatheter Aortic Valve Replacement (TAVR) Revenue (US$ Million) & (2018-2023)
5.9.5 Suzhou Jiecheng Medical Technology Co. Recent Developments
5.10 Peijia Medical
5.10.1 Peijia Medical Profile
5.10.2 Peijia Medical Main Business
5.10.3 Peijia Medical Transcatheter Aortic Valve Replacement (TAVR) Products, Services and Solutions
5.10.4 Peijia Medical Transcatheter Aortic Valve Replacement (TAVR) Revenue (US$ Million) & (2018-2023)
5.10.5 Peijia Medical Recent Developments
6 North America
6.1 North America Transcatheter Aortic Valve Replacement (TAVR) Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Transcatheter Aortic Valve Replacement (TAVR) Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Transcatheter Aortic Valve Replacement (TAVR) Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Transcatheter Aortic Valve Replacement (TAVR) Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Transcatheter Aortic Valve Replacement (TAVR) Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Transcatheter Aortic Valve Replacement (TAVR) Market Dynamics
11.1 Transcatheter Aortic Valve Replacement (TAVR) Industry Trends
11.2 Transcatheter Aortic Valve Replacement (TAVR) Market Drivers
11.3 Transcatheter Aortic Valve Replacement (TAVR) Market Challenges
11.4 Transcatheter Aortic Valve Replacement (TAVR) Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
